Inventor · disambiguated record
Nassim Djebli
Also filed as: DJEBLI NASSIM
1 granted patent·3 pending applications·0 citations·filing 2022–2024
13Inventor score
Files withHOFFMANN LA ROCHE4
Top patents by PatentIndex Score
4 records- 0161US2025206835A1Dosing for combination treatment with anti-cd20/anti-cd3 bispecific antibody and anti-cd79b antibody drug conjugateHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0256US12195547B2Dosing for combination treatment with anti-CD20/anti-CD3 bispecific antibody and anti-CD79B antibody drug conjugateHOFFMANN LA ROCHE·Filed 2022·Granted Jan 14, 2025·0 cites·28 claims
- 0347US2022372156A1Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0445US2023414750A1Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapyHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nassim Djebli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →